Ascendiant Capital Markets Cuts GRI Bio (NASDAQ:GRI) Price Target to $34.00
GRI Bio (NASDAQ:GRI – Get Free Report) had its target price cut by research analysts at Ascendiant Capital Markets from $40.00 to $34.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $10.00 price objective on shares […]
GRI Bio (NASDAQ:GRI – Get Free Report) had its target price cut by research analysts at Ascendiant Capital Markets from $40.00 to $34.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $10.00 price objective on shares […]
